Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: The results of a prospective nationwide study of oncology practice

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 6, Issue 2, 2008, Pages 109-118

  Crawford, Jeffrey ^a   Dale, David C ^b   Kuderer, Nicole M ^a   Culakova, Eva ^a   Poniewierski, Marek S ^a   Wolff, Debra ^b   Lyman, Gary H ^a,c  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cancer; Chemotherapy; Fever; Infection; Neutropenia

Indexed keywords

ANTHRACYCLINE DERIVATIVE; COLONY STIMULATING FACTOR; PLATINUM DERIVATIVE; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER REGISTRY; CLINICAL FEATURE; CLINICAL PRACTICE; COLORECTAL CANCER; COMMUNITY ASSESSMENT; DISEASE SEVERITY; FEBRILE NEUTROPENIA; FEMALE; HODGKIN DISEASE; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OVARY CANCER; PATIENT INFORMATION; PROSPECTIVE STUDY; RISK ASSESSMENT; SMALL CELL CARCINOMA;

EID: 40349102122     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2008.0012     Document Type: Article

References (29)